Accès ouvert déclaré
2024
article
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view
Antonella Cingolani, A Tavelli, S De Benedittis, Ilaria Mastrorosa, Camilla Muccini, Teresa Bini, Anna Carraro, Michele Compagno, Maria Mazzitelli, Marta Guastavigna, Massimo Cernuschi, Carlo Torti, Andrea Antinori, Antonella d’Arminio Monforte, Spinello Antinori, Antonella Castagna, Roberto Cauda, Giovanni Di Perri, Enrico Girardi, R Iardino, Adriano Lazzarin, Giulia Marchetti, C Mussini, Eugenia Quirós-Roldán, Loredana Sarmati, Barbara Suligoi, F von Schloesser, P. Viale, F Ceccherini-Silberstein, Alessandro Cozzi‐Lepri, Antonio Di Biagio, Andrea Gori, Sergio Lo Caputo, G Marchetti, Franco Maggiolo, Massimo Puoti, Carlo Federico Perno, Carlo Torti, Francesca Bai, Alessandra Bandera, Stefano Bonora, Andrea Calcagno, Diana Canetti, A Cervo, Paola Cinque, Roberta Gagliardini, Andrea Giacomelli, Nicola Gianotti, Giovanni Guaraldi, Simone Lanini, Giuseppe Lapadula, Miriam Lichtner, Alessia Lai, Giordano Madeddu, Vincenzo Malagnino, Annalisa Mondi, Valentina Mazzotta, Silvia Nozza, Stefania Piconi, Carmela Pinnetti, Roberto Rossotti, Stefano Rusconi, Maria Mercedes Santoro, Annalisa Saracino, Vincenzo Spagnuolo, Nicola Squillace, Valentina Svicher, L Taramasso, Alessandra Vergori, Iuri Fanti, M Giotta, Cécilia Marelli, A Rodano’, L Cosmaro, A Perziano, Valeria Calvino, Danilo Russo, M Farinella, Nicoletta Policek, V L Del Negro, Matteo Augello, Silvia Carrara, Silvia Graziano, Gennaro Prota, S Truffa, Donatella Vincenti, Roberta Rovito, Andrea Giacometti, Andrea Costantini, V Barocci, Carmen Rita Santoro, Eugenio Milano, Laura Comi, Claudia Suardi, Leonardo Badia, Silvia Cretella, E M Erne, A Pieri, Emanuele Focà, C Minardi, B Menzaghi, C Abeli, Luchino Chessa, Francesco Pes, Paolo Maggi, Loredana Alessio, Giuseppe Nunnari, Benedetto Maurizio Celesia, Jacopo Vecchiet, Katia Falasca, Angelo Pan, Sarah Dal Zoppo, Daniela Segala, Massimo Antonio Di Pietro, Cecilia Costa, Sergio Ferrara, Matteo Bassetti, Emanuele Pontali, Sophie Blanchi, Nicoletta Bobbio, Giovanni Mazzarello, Laura Fondaco, Chiara Molteni, G Canavesi, G Pellicanò, Gloria Montenegro Rizzardini, Valeria Bono, Maria Vittoria Cossu, Riccardo Lolatto, M C Moioli, Laura Pezzati, S Diotallevi, Camilla Tincati, M Menozzi, Paolo Bonfanti, Vincenzo Sangiovanni, Ivan Gentile, Vincenzo Esposito, Nicola Coppola, Francesco Maria Fusco, Giovanni Di Filippo, Vincent Rizzo, N Sangiovanni, Salvatore Martini, Anna Maria Cattelan, D Leoni, Antonio Cascio, Marcello Trizzino, Daniela Francisci, Elisabetta Schiaroli, Giustino Parruti, Federica Sozio, D Messeri, Sara Irene Bonelli, C Lazzaretti, R Corsini, Claudio Maria Mastroianni, Alessandra Latini, Silvia Lamonica, M Capozzi, Marta Camici, Marco Rivano Capparuccia, Giancarlo Iaiani, C Stingone, L Gianserra, Jessica Paulicelli, Maria Maddalena Plazzi, G d’Ettore, Marisa Fusto, I Coledan, Andrea De Vito, Massimiliano Fabbiani, Francesca Montagnani, Alfredo Franco‐Obregón, Rosario Vecchio, B M Pasticci, C Di Giuli, Giancarlo Orofino, Guido Calleri, Giacomo Accardo, Carlo Tascini, Alejandra Londero, Giuliana Battagin, S Nicolè, Giulio Starnini, Serena Dell’Isola
2Citations signalées — pas une note de qualité
12Institutions déclarées
1Pays d’affiliation déclarés
Résumé fourni par la source
BACKGROUND: Implementation level of long-acting injectable agents cabotegravir/rilpivirine (LAI CAB/RPV) for human immunodeficiency virus (HIV) treatment in Italy is still not known. The aim of this study is to identify the status of implementation of LAI CAB-RPV and its barriers. MATERIALS AND METHODS: A cross-sectional online survey was conducted among infectious diseases (ID) physicians and nurses belonging to the ICONA network in Italy. Three validate 4-items measures were used: Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM) and Feasibility of Intervention Measure (FIM). RESULTS: Out of 61 ICONA centres, 38 (62%) completed the survey: 57.9% were academic centres, 42.1% were hospital-based. In total, 104 respondents were ID physicians (57.4%), 77 were nurses (42.5%); 4.5% of all PWH followed at the 38 centres started LAI CAB/RPV at time of study. Centres taking care of >1000 PWH reported 95% application of procedures for LA implementation, higher than other centres (P = 0.009). Mean score of AIM was (16.0, standard deviation, SD, 3.3), of IAM (16.0, SD 3.0) and FIM (16.0, SD 2.9). A linear correlation was found between AIM and the number of people with HIV who started LAI CAB/RPV (25-50 versus <25, coefficient of correlation [b] 2.57, 95%CI 0.91-4.60, P = 0.004), academic versus hospital-based centres (b -1.59, 95%CI -2.76-0.110044, P = 0.007) and the absence of preliminary systematic assessment of staff (b -1.98, 95%CI -3.31-0.65, P = 0.004). Implementation barriers were not significantly different according to the number of PWH/centre. CONCLUSIONS: LAI CAB/RPV implementation was low, with a great variability according to centre size. Tailored and centre-specific interventions to address barriers and to optimize the LA treatment implementation should be designed.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view
- Date Crossref
- 14/08/2024
- Éditeur
- Oxford University Press (OUP)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.
Institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.
Sujets associés
HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHIV/AIDS drug development and treatment